BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value ($000): $3,568,797 (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 34.8%

Value ($000) $1,241,280 Shares 40,538,196 Est. Cost $17.18 Unrealized +62.1%

— MICHAELS COS INC 24.0%

Value ($000) $856,927 Shares 52,798,929 Est. Cost $17.48 Unrealized —

IQV IQVIA HLDGS INC 13.9%

Value ($000) $495,037 Shares 3,815,315 Est. Cost $101.80 Unrealized +18.0%

SGRY SURGERY PARTNERS INC 12.2%

Value ($000) $436,518 Shares 26,455,651 Est. Cost $14.30 Unrealized +11.6%

— ATENTO S A 10.2%

Value ($000) $363,905 Shares 48,520,671 Est. Cost $10.45 Unrealized —

— VERITIV CORP 2.8%

Value ($000) $101,332 Shares 2,783,840 Est. Cost $50.06 Unrealized —

— FRANKS INTL N V 2.1%

Value ($000) $73,798 Shares 8,506,930 Est. Cost $12.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1,241,280	34.8%	$17.18	+62.1%	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$856,927	24.0%	$17.48	—	COM	59408Q106
IQV	IQVIA HLDGS INC	3,815,315	$495,037	13.9%	$101.80	+18.0%	COM	46266C105
SGRY	SURGERY PARTNERS INC	26,455,651	$436,518	12.2%	$14.30	+11.6%	COM	86881A100
—	ATENTO S A	48,520,671	$363,905	10.2%	$10.45	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$101,332	2.8%	$50.06	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$73,798	2.1%	$12.31	—	COM	N33462107